Allergan, Awaiting Pfizer Deal, Sees Bonds Surge Wider As US Targets Tax Inversions |
| April 06, 2016 | April 2016 Bond Updates |
|
Corpote bonds backing Allergan gapped wider today after the U.S. Department of the Treasury and the Internal Revenue Service yesterday announced a new round of tougher-than-expected measures to curb corporate tax inversions, in a new threat to the company’s planned all-equity merger with Pfizer. |
| View more at: http://www.forbes.com/sites/spleverage/2016/04/05/allergan-awaiting-pfizer-deal-sees-bonds-surge-wider-as-us-targets-tax-inversions/ |
| Related News |